Lv21
120 积分 2024-12-06 加入
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives
9天前
已完结
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
1个月前
已完结
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis
1个月前
已完结
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
4个月前
已完结
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
4个月前
已完结
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
